DNA Group (TR) (XTAE:DNA) EV-to-EBIT : -15.38 (As of May. 01, 2024)

View and export this data going back to 2007. Start your Free Trial

What is DNA Group (TR) EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, DNA Group (TR)'s Enterprise Value is ₪33.43 Mil. DNA Group (TR)'s EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-2.17 Mil. Therefore, DNA Group (TR)'s EV-to-EBIT for today is -15.38.

The historical rank and industry rank for DNA Group (TR)'s EV-to-EBIT or its related term are showing as below:

XTAE:DNA' s EV-to-EBIT Range Over the Past 10 Years
Min: -19.63 Med: -3.56 Max: -0.27
Current: -15.38

During the past 11 years, the highest EV-to-EBIT of DNA Group (TR) was -0.27. The lowest was -19.63. And the median was -3.56.

XTAE:DNA's EV-to-EBIT is ranked worse than
100% of 440 companies
in the Biotechnology industry
Industry Median: 8.725 vs XTAE:DNA: -15.38

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. DNA Group (TR)'s Enterprise Value for the quarter that ended in Dec. 2023 was ₪11.14 Mil. DNA Group (TR)'s EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-2.17 Mil. DNA Group (TR)'s Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -19.51%.

DNA Group (TR) EV-to-EBIT Historical Data

The historical data trend for DNA Group (TR)'s EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Group (TR) EV-to-EBIT Chart

DNA Group (TR) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-0.45

-14.54

-56.42

-4.20

-5.12

DNA Group (TR) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-56.42	-	-4.20	-	-5.12

Competitive Comparison of DNA Group (TR)'s EV-to-EBIT

For the Biotechnology subindustry, DNA Group (TR)'s EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DNA Group (TR)'s EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DNA Group (TR)'s EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where DNA Group (TR)'s EV-to-EBIT falls into.

DNA Group (TR) EV-to-EBIT Calculation

DNA Group (TR)'s EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	33.434	/	-2.174
	=	-15.38

DNA Group (TR)'s current Enterprise Value is ₪33.43 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DNA Group (TR)'s EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-2.17 Mil.

DNA Group (TR) (XTAE:DNA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

DNA Group (TR)'s Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-2.174	/	11.141648
	=	-19.51 %

DNA Group (TR)'s Enterprise Value for the quarter that ended in Dec. 2023 was ₪11.14 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DNA Group (TR)'s EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-2.17 Mil.

DNA Group (TR) EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of DNA Group (TR)'s EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.